Structure-activity relationships for reactivators of organophosphorus-inhibited acetylcholinesterase: quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 1984

C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley

A series of 1,3-disubstituted-2-[(hydroxyimino)methyl]imidazolium halides were prepared and evaluated in vitro with respect to their ability to reactivate acetylcholinesterase inhibited by ethyl p-nitrophenyl methylphosphonate (EPMP) and 3,3-dimethyl-2-butyl methylphosphonofluoridate (GD). The compounds conform to the general formula N(CH3)C(CHNOH)N(CH2OR)CHCH+ X Cl-, where R = CH3, (CH2)3CH3, (CH2)7CH3, CH2C6H5, CH2C10H7, (CH2)3C6H5, CH(CH3)2, CH2C(CH3)3, and CH(CH3)C(CH3)3. For comparison we also evaluated three known pyridinium reactivators, 2-PAM, HI-6, and toxogonin. The imidazolium aldoximes exhibit oxime acid dissociation constants (pKa) in the range 7.9-8.1, bracketing the value of 8.0, believed to be optimal for acetylcholinesterase reactivation. With imidazolium compound in excess over inhibited enzyme, the kinetics of reactivation are well behaved for EPMP-inhibited AChE and depend on the nature of the alkyl ether group R. For GD-inhibited AChE, maximal reactivation was used to compare compounds because rapid phosphonyl enzyme dealkylation and enzyme reinhibition complicate interpretation of kinetic constants.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004524 Eels Common name for an order (Anguilliformes) of voracious, elongate, snakelike teleost fishes. Anguilliformes,Eel
D006898 Hydroxylamines Organic compounds that contain the (-NH2OH) radical.
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012999 Soman An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent. Pinacolyl Methylphosphonofluoridate,Methylphosphonofluoridate, Pinacolyl
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
April 1972, Journal of pharmaceutical sciences,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
January 1972, Il Farmaco; edizione scientifica,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
August 1973, Journal of medicinal chemistry,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
May 1970, Journal of pharmaceutical sciences,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
July 1969, Journal of pharmaceutical sciences,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
November 1975, Journal of medicinal chemistry,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
January 1985, Journal of medicinal chemistry,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
August 1975, Journal of medicinal chemistry,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
January 1974, Journal of medicinal chemistry,
C D Bedford, and R N Harris, and R A Howd, and A Miller, and H W Nolen, and R A Kenley
December 1977, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!